FDA Denies Approval For Stroke Drug
Topics
Developing
- 862d Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore.
- 862d Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur.
- 862d Excepteur sint occaecat cupidatat non proident, sunt in culpa qui officia deserunt mollit anim id est.
- 862d Sed ut perspiciatis unde omnis iste natus error sit voluptatem accusantium doloremque laudantium.
Sources · 7 independent
“The FDA is denying approval for a grace therapeutics drug intended to treat a rare but often deadly type of stroke. The agency says it has issues with the chemistry, manufacturing, and controls of the New Jersey based companies.”
“The FDA is denying approval for a grace therapeutic drug intended to treat a rare but often deadly type of stroke. The agency says it has issues with the chemistry, manufacturing, and controls of the New Jersey based companies' stroke drug.”
“The FDA is denying approval for a grace therapeutics drug intended to treat a rare but often deadly type of stroke. The agency says it has issues with the chemistry, manufacturing and controls of the New Jersey based companies stroke drug.”
Unlock the full story
Get a Pro subscription or above to see the live story progression and the full list of independent sources confirming each event as they happen.
Log in to upgrade